)
)
)
)
)
Cellmover: Norwegian biotechnology success paves the way for new cancer treatment
Cellmover is now making great strides in developing next-generation cancer therapies. The company has recently secured funding through the Eurostars program, and CSO Miriam Aarsund Larsen has been named one of Norway's 50 leading women in technology. How did she transition from researcher to leader, and what is driving Cellmover forward?
)
)
)
)
)